Prostate Health Index (PHI) Test
- Widespread prostate cancer screening with prostate-specific antigen (PSA) has led to a reduction in the proportion of men diagnosed with metastatic disease and prostate cancer death. However, PSA screening continues to be controversial due to its limited specificity for clinically significant prostate cancer, resulting in unnecessary biopsies for false positive results as well as the detection of some indolent tumors that would not have caused harm during the patient’s lifetime.
- To preserve the benefits of screening and early detection, and to reduce these harms, alternative ways of using the PSA test with better performance characteristics have been suggested.
- Several PSA isoforms have been identified that can further increase the specificity for prostate cancer. In particular, the p2PSA ([-2] form of pro PSA) has been seen to have improved performance over either total or free PSA for prostate cancer detection on biopsy.
- The phi (Prostate Health Index) is a multifactorial mathematical combination of PSA, fPSA, and p2PSA ([-2]proPSA) concentrations designed to optimize clinical sensitivity and specificity to aid in the determination of the risk of prostate cancer.
- The significantly higher specificity of phi means a greater probability of detecting those patients who need a biopsy, allowing for a substantial decrease in the number of prostate biopsies that are reported as negative for cancer. phi has the potential to reduce negative biopsies by ~30%.
- Low PHI has been seen to be associated with a lower risk of having prostate cancer and higher scores are associated with an increased risk.
- phi is three times more specific than PSA for detecting prostate cancer and it fills the diagnostic gap between PSA screening and a prostate biopsy.
- Combined with family and patient history, the phi results can be used to determine the best-individualized patient management decisions.
- phi is a simple and inexpensive blood test that should be used as part of a multivariable approach to screening and may be considered as part of the standard urologic armamentarium for biopsy decisions, risk stratification, and treatment selection for suspected prostate cancer.
Symptoms that may call for a Prostate Health Index (PHI) Test
Prostate cancer often does not show any symptoms in its early stages. However, as cancer starts progresses, the following symptoms may start to appear such as:
- Frequent urination especially at night
- Difficulty urinating
- Blood in urine or semen
- Pain or discomfort during ejaculation
- Pain or discomfort in the lower back, hips, or thighs
If you experience any of these symptoms, it's crucial to prioritize your health and schedule a Prostate Health Index (PHI) test today!
|Name of the Test
|| Prostate Health Index (PHI)
|Number Of Tests
|Home Sample Collection
|Additional Cost For Home Sample Collection
|Fasting Before Test
|Get Reports Within
Purpose of Prostate Health Index (PHI)
- To improve accuracy in prostate cancer detection
- To reduce unnecessary biopsies
- To monitor disease progression
- To screen in High-risk groups
- To measure PSA in your blood
Why choose Redcliffe Labs?
- Home-sample collection process
- NABL & ISO accredited Labs
- Provides smart test reports
- Free doctor consultation
- Trusted by 50,000+ doctors
- Follows patient-centric approach
Prostate cancer is a serious illness that can spread to other body parts and become the cause of death. Before it gets too late, it is essential to take preventive measures because precaution is always better than cure. Make your health your priority and undergo a prostate health index test with Redcliffe Labs. Experience the fastest diagnostic experience by getting tested within 45 minutes. Book now!